Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Older men with lower levels of available testosterone are more likely to be frail.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Genomic approach finds new possible treatments for hair loss.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Vav2 changes how hair follicle stem cells' genes work as they age, which might improve regeneration but also raise cancer risk.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

New genes found linked to balding, may help develop future treatments.

The conclusion is that the nuclear lamina and LINC complex in skin cells respond to mechanical signals, affecting gene expression and cell differentiation, which is important for skin health and can impact skin diseases.

Hoxc genes control hair growth through Wnt signaling.

Mice with human gene experienced hair loss when treated with DHT.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.